BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duran CE, Ramírez A, Posada JG, Schweineberg J, Mesa L, Pachajoa H, Estacio M, Manzi E, Aros V, Díaz L, Garcia VH. Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country. Int J Nephrol 2019;2019:7076326. [PMID: 31929905 DOI: 10.1155/2019/7076326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Daehn IS, Duffield JS. The glomerular filtration barrier: a structural target for novel kidney therapies. Nat Rev Drug Discov 2021. [PMID: 34262140 DOI: 10.1038/s41573-021-00242-0] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
2 Watanabe A, Guaragna MS, Belangero VMS, Casimiro FMS, Pesquero JB, de Santis Feltran L, Palma LMP, Varela P, de Menezes Neves PDM, Lerario AM, de Souza ML, de Mello MP, de Brito Lutaif ACG, Ferrari CR, Sampson MG, Onuchic LF, Nogueira PCK. APOL1 in an ethnically diverse pediatric population with nephrotic syndrome: implications in focal segmental glomerulosclerosis and other diagnoses. Pediatr Nephrol 2021;36:2327-36. [PMID: 33585978 DOI: 10.1007/s00467-021-04960-w] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Duran CE, Ramírez A, Posada JG, Schweineberg J, Mesa L, Pachajoa H, Estacio M, Manzi E, Aros V, Díaz L, Garcia VH. Corrigendum to "Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country". Int J Nephrol 2020;2020:8706297. [PMID: 33294227 DOI: 10.1155/2020/8706297] [Reference Citation Analysis]